Related Experiment Video
Updated: Aug 11, 2026

14:58
Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Clinical analysis of vertebrobasilar dissection
1Department of Neurosurgery, Kangwon National University College of Medicine, Chuncheon, Korea.
Acta Neurochirurgica
|March 3, 2006
Summary
Vertebrobasilar artery dissection (VAD) outcomes depend on presentation. Patients with subarachnoid hemorrhage (SAH) require intervention, while those without SAH may be managed conservatively.
Area of Science:
- Neurology
- Vascular Surgery
- Neuroradiology
Background:
- The natural history and optimal management of vertebrobasilar artery dissection (VAD) remain incompletely understood.
- This study reviews clinical outcomes of VAD patients to inform management strategies.
Purpose of the Study:
- To analyze the clinical outcomes of patients diagnosed with vertebrobasilar artery dissection (VAD).
- To propose evidence-based management strategies for VAD based on patient presentation and outcomes.
Main Methods:
- Retrospective review of 35 VAD patients (1992-2004).
- Analysis of patient demographics, clinical presentation (including subarachnoid hemorrhage - SAH), angiographic findings (shape, location relative to PICA), and treatment modalities.
- Functional outcomes assessed using the modified Rankin score and analyzed against various clinical and angiographic factors.
Main Results:
- No significant difference in functional outcome based on age, gender, trauma history, or hypertension.
- Patients presenting without subarachnoid hemorrhage (SAH) had significantly better functional outcomes than those with SAH (p=0.029).
- Hunt-Hess grade showed statistical significance with clinical outcome (p=0.032); aneurysm presence correlated with rebleeding and mortality.
Conclusions:
- Vertebrobasilar artery dissection (VAD) patients with subarachnoid hemorrhage (SAH) benefit from surgical or endovascular treatment.
- Conservative management with antiplatelet or anticoagulation therapy is suitable for VAD patients without SAH.

